XML 41 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Note 13 - Segment Information (Tables)
3 Months Ended
Sep. 30, 2021
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
  

Quarter Ended

 
  

September 30,

 
  

2021

  

2020

 

Net sales:

        

Protein Sciences

 $197,186  $154,446 

Diagnostics and Genomics

  60,985   50,125 

Intersegment

  (452

)

  (372

)

Consolidated net sales

 $257,719  $204,199 

Operating income:

        

Protein Sciences

 $90,100  $70,352 

Diagnostics and Genomics

  7,463   8,674 

Segment operating income

  97,563   79,026 
Costs recognized on sale of acquired inventory  (1,512)   - 

Amortization of acquisition related intangible assets

  (18,389

)

  (15,501

)

Impact of partially owned consolidated subsidiaries  (1,562)  - 

Acquisition related expenses

  2,377

 

  (136

)

Stock-based compensation, inclusive of employer taxes

  (13,860

)

  (13,333

)

Restructuring costs  (1,185)  - 

Corporate general, selling, and administrative expenses

  (210

)

  (964

)

Consolidated operating income

 $63,222  $49,092